Download Citation on ResearchGate | On Dec 1, , Edwin Arévalo Guerrero and others published Rol del strain miocárdico en. Abstract. RUIZ-MORI, Enrique; AYALA-BUSTAMANTE, Leonor; BURGOS- BUSTAMANTE, Jorge and PACHECO ROMAN, Cristian. Chemotherapy-induced . Resumen. RUIZ-MORI, Enrique; AYALA-BUSTAMANTE, Leonor; BURGOS- BUSTAMANTE, Jorge y PACHECO ROMAN, Cristian. Chemotherapy-induced.

Author: Fenrizilkree Taujar
Country: Congo
Language: English (Spanish)
Genre: Life
Published (Last): 6 June 2007
Pages: 81
PDF File Size: 19.94 Mb
ePub File Size: 14.56 Mb
ISBN: 829-2-23025-184-3
Downloads: 48459
Price: Free* [*Free Regsitration Required]
Uploader: Dijar

Late effects of breast cancer treatment and potentials for rehabilitation. Anderson Cancer Center experience. Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells.

Radiation dose-volume effects in the heart. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. Protective effects of carvedilol against anthracycline-induced cardiomyopathy.

Cardiovascular complications of cancer therapy: Cardiovascular toxicity of some cancer agents others than anthracyclines, fluoropyrimidines and trastuzumab. Effect of carvedilol on survival in severe chronic heart failure.

Optimal management of emergent hypertension during treatment with quimioterapla VEGF signaling inhibitor: Insights and perspectives in the era of targeted therapy. Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol. No entanto, alguns estudos merecem destaque pelos seus achados.


Physical activity and public health: Mechanisms of anthracycline cardiac injury: J Sci Med Sport. Cancer is a major public health problem in the world. Cheng H, Force T. Tubulin polymerization modifies cardiac sodium channel expression and gating.

Dexrazoxane in the prevention of doxorubicin-induced cardiotoxicity.

A randomized phase 2 study of lenalidomide pir for patients with relapsed or relapsed and refractory multiple myeloma.

Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy. Antithrombotic therapy for venous thromboembolic disease: Cardiac Society of Australia and New Zealand.

Tex Heart Inst J.

Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy. Meta-analysis of vascular and neoplastic events associated with tamoxifen.

Cardiotoxicidad inducida por quimioterapia.

Singhal S, Mehta J. Snyder Cardiotoxicidd, Greenberg S. Cardiotoxicity of cancer therapy. Santa Clara, CP A prospective randomized evaluation. Pentostatin increases the acute toxicity of high dose cyclophosphamide. Effect of arsenic trioxide on QT interval in patients with advanced malignancies.

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.


[Anthracycline-induced cardiotoxicity: report of fatal cases].

Moreira C, Kaklamani V. How to cite this article. Symptoms and signs of an acute myocardial ischemia caused by chemotherapy with Paclitaxel Taxol in a patient with metastatic ovarian carcinoma.

Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia. Pathophysiology and diagnosis of cancer drug induced cardiomyopathy. Karnofsky performance status revisited: Hemodynamic monitoring in shock and implications for management. Cardiac dysfunction in the trastuzumab clinical trials experience. Am J Clin Pathol.

I Diretriz Brasileira de Cardio-Oncologia da Sociedade Brasileira de Cardiologia

Cardiac and cardiotoxiccidad toxicity of nonanthracycline anticancer drugs. A prognostic model in patients who receive chemotherapy for metastatic or recurrent gastric cancer: Etoposide-related cardiotoxicity in a child with haemophagocytic lymphohistiocytosis. Aspectos fundamentais que devem ser considerados no manejo desses pacientes: Doxorubicin administration by continuous infusion is not cardioprotective:

Author: admin